Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Feb 23, 2017 · 10-K · 54 days after period end · 0001564590-17-002109
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Net Income | -$486.00K | -$1.72M | -$5.68M | -$6.68M |
| EPS Diluted | -$22.89 | $0.06 | -$0.26 | -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Feb 23, 2017 · 54 d after period end
